ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 114

Persistent Synovial Resident Memory T Cells Mediate Arthritis Flares

Margaret Chang1, Anaïs Levescot 2, Rachel Blaustein 2, Nathan Nelson-Maney 2, Allyn Morris 2, Robert Fuhlbrigge 3 and Peter Nigrovic 4, 1Division of Immunology, Boston Children's Hospital, Boston, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, 3Department of Rheumatology, Children’s Hospital Colorado, Denver, CO, 4Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA ; Department of Medicine, Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA., Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Arthritis, flare, memory, T cells and synovium

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Resident memory T cells (TRM) are site-specific memory T cells that take up long-term residence in peripheral tissues and aid in pathogen defense. However, TRM cells can also drive localized, recurrent inflammation. RA and JIA are characterized by recurrent joint inflammation that exhibits a strong tendency to flare at the same sites. We previously created a novel murine model of recurrent, joint-specific inflammation and demonstrated a population of memory T cells with a TRM cell phenotype (CD45+CD3+CD8+CD44+CD62L-CD69hi). Here, we characterize the persistence of these synovial resident memory T cells and their role in arthritis flares.

Methods: Localized arthritis is established by intra-articular (IA) injection of methylated bovine serum albumin (meBSA) or ovalbumin (OVA) with concurrent IL-1beta injections to the footpad to stimulate an immune response. Spontaneous remission occurs after 28 days, but arthritis flares in the original joints when re-stimulated with intraperitoneal meBSA or OVA. To track the site-specific persistence of TRM cells, we labelled synovial T cells using fluorescent reporter mice and IA injection of adeno-associated virus (AAV). To assess the importance of lymphocyte recruitment to an arthritis flare, we treated mice with FTY720, a sphingosine-1 phosphate receptor modulator that sequesters lymphocytes in lymphoid tissues, and evaluated joint inflammation after triggering a flare. Finally, to demonstrate the contribution of synovial TRM cells to the flare response, we locally depleted synovial T cells with a single IA injection of diphtheria toxin into mice with Lck-inducible diphtheria toxin receptors prior to triggering an arthritis flare.

Results: We found that synovial TRM cells persist in previously inflamed joints 8 months after remission and retained their capacity to trigger a flare in a site-specific manner. AAV-labelled TRM cells present in the synovium during remission did not migrate to the contralateral joint. TRM cells enabled joint inflammation by recruiting effector lymphocytes to the joint, and correspondingly localized depletion strongly blunted the capacity to flare arthritis.

Conclusion: Synovial TRM cells persist in arthritic joints and retain their capacity to trigger a site-specific flare after prolonged periods of remission. Our data suggest that synovial resident memory T cells can mediate joint-specific memory in inflammatory arthritis and trigger flares by recruiting circulating lymphocytes, suggesting local depletion of TRM cells as a potential therapeutic strategy.


Disclosure: M. Chang, None; A. Levescot, None; R. Blaustein, None; N. Nelson-Maney, None; A. Morris, None; R. Fuhlbrigge, CARRA, 6, 9; P. Nigrovic, None.

To cite this abstract in AMA style:

Chang M, Levescot A, Blaustein R, Nelson-Maney N, Morris A, Fuhlbrigge R, Nigrovic P. Persistent Synovial Resident Memory T Cells Mediate Arthritis Flares [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/persistent-synovial-resident-memory-t-cells-mediate-arthritis-flares/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/persistent-synovial-resident-memory-t-cells-mediate-arthritis-flares/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology